A one-year, multi-national, open-labelled, parallel-group, 2:1 randomised treat-to-target trial comparing efficacy and safety of insulin detemir with insulin glargine using a basal-bolus regimen with insulin aspart as mealtime insulin in subjects with type 1 diabetes To compare the glycaemic control of insulin detemir with that of insulin glargine as measured by HbA1c in subjects with type 1 diabetes on a basal-bolus regimen with insulin aspart as bolus insulin af...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

NordiNet International Outcome Study (NordiNet IOS) To collect the post-marketing data on effectiviness and safety of real-life treatment with Norditropin.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A one-year, multi-national, open-labelled, parallel-group, 2:1 randomised treat-to-target trial comparing efficacy and safety of insulin detemir with insulin glargine using a basal-bolus regimen with insulin aspart as mealtime insulin in subjects with type 2 diabetes To compare the glycaemic control of insulin detemir with that of insulin glargine as measured by HbA1c in subjects with type 2 diabetes on a basal-bolus regimen with insulin aspart as bolus insulin af...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune